Metabolomics Uncovers Biomarkers for PCOS Diagnosis and Therapy – JMSACL
JMSACL (Journal of Mass Spectrometry and Advances in the Clinical Lab) shared a post on LinkedIn:
“Source: (Journal of ovarian research)
Study on PCOS via mass spectrometry metabolomics identified 49 serum metabolites, with 39 upregulated and 10 downregulated. Key findings include altered lipid and amino acid metabolism, revealing candidate biomarkers for diagnosis and therapy. Metabolic pathways affected include sphingolipid metabolism.”
Title: Mass spectrometry-based untargeted metabolomics study of polycystic ovary syndrome
Authors: Ömer Faruk Özer, Ayşe Zeynep İbrahimoğlu, Ayşe Zehra Gül, Metin Demirel, Seda Ateş, Havva Sevde Taha, Merve İbrahimoğlu, Şahabettin Selek
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Mar 21, 2026, 15:00Samantha Butts Shares Personal and Professional Insights in ASRM Close Up
-
Mar 21, 2026, 14:47Scammers Are Targeting ESHRE2026 Attendees – ESHRE
-
Mar 21, 2026, 14:26No Obvious Harm From Prolonged Oocyte Cryostorage – RBMO
-
Mar 21, 2026, 14:13Empowering Change: Health Systems at the Forefront of Ending FGM/C! – FIGO
-
Mar 21, 2026, 09:56Expanded Carrier Screening: Clinical, Ethical, and Psychosocial Perspectives from Ghent – ESHRE
-
Mar 21, 2026, 09:53Impact of Male Obesity on Embryo Development and Miscarriage Risk – Fertility and Sterility
-
Mar 20, 2026, 17:06Christopher Robinson: AJOG Expert Review on Placenta Accreta After Cesarean
-
Mar 20, 2026, 16:53HCG Failure and Trigger Strategies in IVF – Fertility Plus
-
Mar 20, 2026, 16:38Secure Your Early Bird Ticket for RCOG Annual Professional Development Conference – RCOG